Fintech– 0

MapLight Therapeutics GAAP EPS Reported

Seekingalpha·March 26, 2026 at 11:49 AM

MapLight Therapeutics, Inc. has reported its Generally Accepted Accounting Principles (GAAP) earnings per share (EPS) as -$2.47. This figure reflects the company's financial performance during the specified reporting period. Further details regarding revenue, net income, and operational expenses would be necessary to provide a comprehensive analysis of the company's financial health and future outlook.

MapLight Therapeutics GAAP EPS Reported

Wells Fargo virtual assistant aids over 1 billion transactions

White House crypto czar joins science advisory committee

David Sacks leaves crypto post for White House

Lawmakers Question Bank Regulators on Fintech Rules